SOUTH
PLAINFIELD, N.J., Feb. 27,
2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ:
PTCT) today announced that the company will present a company
overview at the following conferences:
TD Cowen 44th Annual Health Care
Conference
Monday, March 4,
at 1:30 p.m. EST
Leerink Partners Global Biopharma Conference
2024
Monday, March 11, at
2:40 p.m. EDT
Barclays 26th Annual Healthcare
Conference
Tuesday, March
12, at 4:05 p.m. EDT
The presentations will be webcast live on the Events and
Presentations page under the Investor section of PTC Therapeutics'
website at https://ir.ptcbio.com/events-presentations and will be
archived for 30 days following the presentation. It is recommended
that users connect to PTC's website several minutes prior to the
start of the webcast to ensure a timely connection.
About PTC Therapeutics, Inc.
PTC is a science-driven,
global biopharmaceutical company focused on the discovery,
development and commercialization of clinically differentiated
medicines that provide benefits to patients with rare disorders.
PTC's ability to globally commercialize products is the foundation
that drives investment in a robust and diversified pipeline of
transformative medicines and our mission to provide access to
best-in-class treatments for patients who have an unmet medical
need. The Company's strategy is to leverage its strong scientific
expertise and global commercial infrastructure to maximize value
for its patients and other stakeholders. To learn more about PTC,
please visit us at www.ptcbio.com and follow us on Instagram,
Facebook, Twitter, and LinkedIn.
For More Information:
Investors:
Kylie
O'Keefe
+1 (908) 300-0691
kokeefe@ptcbio.com
Media:
Jeanine
Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original
content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conferences-302073358.html
SOURCE PTC Therapeutics, Inc.